NOT-DA-13-027: Notice to Clarify Number of Applications Allowed per Institution for RFA-DA-14-004 Medications Development Centers of Excellence Cooperative Program (U54)

Department of Health
and Human Services (HHS)

NIH... Turning Discovery Into Health^®

Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.

Notice to Clarify Number of Applications Allowed per Institution for RFA-DA-14-004 "Medications Development Centers of Excellence Cooperative Program (U54)"

Notice Number: NOT-DA-13-027

Key Dates

Release Date: May 6, 2013

Related Announcements

RFA-DA-14-004

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice is to clarify that the number of applications allowed per institution for NIDA's RFA-DA-14-004 “Medications Development Centers of Excellence Cooperative Program (U54)” is only one.

The following section of RFA-DA-14-004 is modified accordingly.

Part 2. Section III.3. Additional Information on Eligibility

Number of Applications

Current Language:

Applicant organizations may submit more than one application, provided that each application is scientifically distinct.

Modified Language:

Only one application per institution, identified by a unique DUNS number, is allowed.

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Jamie Biswas, Ph.D.
Division of Pharmacotherapies and Medical Consequences of Drug Abuse
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-8096
Email: jbiswas@mail.nih.gov